Concise and to-the-point…

… is how texts should be. The first few lines need to grab the reader's attention! Make sure the beginning is exciting – arouse curiosity and an appetite for “more”. Clear facts: brief, transparent, genuine.

We research the material, provide background and show how an innovation can help society. We get scientists, technicians and experts to voice their personal opinions.

Maybe you have signed a secrecy agreement with your industrial partner or perhaps you haven’t yet finalised your patent application? But even so, we can still make sure your text packs a punch.

Tell us what you need! We’ll deliver the goods – just how you want them.

Where do Personalized Health Technologies stand today?

For years biotechnet Switzerland has provided access to biotechnology capacity at Swiss universities of applied sciences, universities and research centres. Innovative companies put their trust in its support and services in research, development and training. Now two of the individuals who have made biotechnet what it is while keeping it on course for the future are departing.

The New, Stringent MDR and IVDR Regulations
Viewing this Change as an Opportunity

Chimia 72, No. 6

Abstract: The healthcare and life science sector is growing inexorably,and is now a multi-billion dollar industry. In 2016 the companies in this sector posted sales of USD 140 billion, and their profitability more than doubled by comparison with 2010. The pharmaceutical, diagnostics, medtech and chemical sectors have become Switzerland’s most powerful export industry, and significant number of approved medications and diagnostics contain biotech elements.

Look to the skies

Intersec April 2018

Drones are opening up hitherto unimagined prospects. Originally developed for combat and military surveillance purposes, they are being increasingly used in civilian applications. But in 2015, a quadrocopter spooked security forces by crashing in front of the White House in Washington, and in early 2017 security personnel in Davos grounded drones that were merrily flying over the World Economic Forum despite a flight ban. The School of Engineering at Bern University of Applied Sciences (BFH) has an efficient remedy for such cases.

Quo Vadis Point-of-Care Diagnostics?

Report II of the SWISS SYMPOSIUM in Point-of-Care Diagnostics 2017

Marc E. Pfeifer*

U.S. studies show that the global point-of-care (POC) diagnostics market will reach $40.5 bn by 2022, with a compound annual growth rate (CAGR) of 10%.[1] This is one of the reasons why HES-SO Valais-Wallis and CSEM, acting on behalf of the NTN Swiss Biotech thematic platform in vitro Diagnostics (TP IVD), invited interested parties on October 26, 2017 to the SWISS SYMPOSIUM in Point-of-Care Diagnostics (see CHIMIA No. 12/2017).[2] We now bring the second report on the future prospects of POC diagnostics.

TEDD Annual Meeting with 3D Bioprinting Workshop

Michael Raghunath*, Markus Rimann*, Katarzyna S. Kopanska*, and Sandra Laternser*

Bioprinting is the technology of choice for realizing functional tissues such as vascular system, muscle, cartilage and bone. In the future, bioprinting will influence the way we engineer tissues and bring it to a new level of physiological relevance. That was the topic of the 2017 TEDD Annual Meeting at ZHAW Waedenswil on 8th and 9th November. In an exciting workshop, the two companies regenHU Ltd. and CELLINK gave us an insight into highly topical applications and collaborations in this domain.

Off they go: Single-use Technology in Future Production

“Keep up with today’s single-use technology standard but also remain one step ahead” – that could have been the motto of the BioTech 2016 conference at ZHAW Waedenswil on September 5 and 6, which brought together manufacturers, suppliers, users, regulatory specialists and representatives of organizations in this field to implement single-use devices all over the world. It was an effectiveness analysis of the trend to replace reusable equipment in production facilities with single use components.

Thanks for the Clever ‘String Pullers’ at biotechnet

For years biotechnet Switzerland has provided access to biotechnology capacity at Swiss universities of applied sciences, universities and research centres. Innovative companies put their trust in its support and services in research, development and training. Now two of the individuals who have made biotechnet what it is while keeping it on course for the future are departing.

The 2016 Olten Meeting at the Basel Life Science Week

"This ‘telephone’ has too many shortcomings to be seriously considered as a means of communication. The device is inherently of no value to us.” This was an internal memo written by Western Union in 1876. That’s right. Without efficient knowledge sharing and technology transfer, even the best scientific development may prove to be a damp squib for a long time. The Basel Life Science Week was created in order to promote scientific and economic exchange and pave the way for innovative ideas. That’s why NTN Swiss Biotech has moved its traditional ‘Olten Meeting’ to the Basel Life Science Week. It is the ideal setting for NTN Swiss Biotech and the School of Life Sciences FHNW to present innovative developments within its network of academic and industrial partners in the futureoriented disciplines of Molecular Diagnostics and Medicinal Chemistry. 

2016 TEDD Annual Meeting ZHAW Wädenswil

The focus of the 2016 TEDD Annual Meeting – the Competence Centre for Tissue Engineering for Drug Development and Substance Testing – was on current segments of the 3D cell culture market, especially scaffold-free and scaffold-based cell culture, as well as bioprinting, and the use of recellularized tissues. Particular emphasis was placed on metabolic tissue engineering, specifically the generation of human brown fat cells from progenitor cells. Let’s take a look behind the scenes of the latest developments.

Innovation Centre Peptide and Protein Technologies

HES-SO Technologies du vivant
(Denis Emery /

HES-SO Sion: Pioneer in an Emerging Market

Peptides are small proteins typically containing a chain of up to 100 amino acids. In our bodies, they are produced every day in vast quantities and perform highly specific biological activities. As there is an increased interest in peptides for pharmaceutical applications, the HES-SO Valais-Wallis created a research group to focus on Peptide and Protein Technologies (P2T).

Biosorption at the HES-SO Valais-Wallis Sion

Looking for Partners to Implement Innovative Technologies

Water pollution contributes to a number of health problems and disorders in humans, and dramatically affects wild animals and the environment as a whole. Biosorption is a sound and sustainable way to remove pollutants like metals, dyes, phenols, pesticides or drug metabolites from liquid effluents. But despite active research worldwide, technical limitations still impede its widespread use. At HES-SO Valais-Wallis in Sion, Prof. Simon Crelier is working on the development of efficient, economically viable and scalable biosorption processes.

The State of the Art of 3D Cell Cultures

DECHEMA Conference in Freiburg 2016

Where are we today with 3D cell cultures as predictive, physiologically relevant model systems? Are there any successful applications, innovative developments or yawning gaps? The DECHEMA April conference assembled international experts to take a look behind the scenes and reveal relevant disease models, applications of 3D models in clinical practice and industry, predictive cell models for compound characterization and enabling technologies.

Incredibly Versatile Microbial Fuel Cells

Innovative Ideas at HES-SO Valais-Wallis for Solving Topical Problems

At HES-SO Valais-Wallis, Prof. Fabian Fischer is specialized in microbial fuel cells for novel applications that meet the challenge of producing renewable energies. He and his team possess a unique expertise in bioelectric energy vector generation, phosphate extraction (CHIMIA 2015, 69, 296) and the testing of antimicrobial surfaces. Let’s take a look behind the scenes of the Institute of Life Technologies in Sion.

A Fresh Wind is Blowing in from Asia

Professor Michael Raghunath Arrives at ZHAW Waedenswil

Prof. Michael Raghunath interviewed by Elsbeth Heinzelmann

In summer 2016, Michael Raghunath from the National University of Singapore (NUS) will take over the professorship from Ursula Graf-Hausner in cell culture technology and tissue engineering at ZHAW Life Sciences and Facility Management. What are his objectives and the corresponding strategies? What challenges will he face, what will he choose to focus on? Michael Raghunath was kind enough to let us have a look behind the scenes.